Treatment of uncomplicated urinary tract infection in non-pregnant women.
about
Interventions for preventing recurrent urinary tract infection during pregnancyInterventions for preventing recurrent urinary tract infection during pregnancyInterventions for preventing recurrent urinary tract infection during pregnancyRandomised controlled trial of nitrofurantoin versus placebo in the treatment of uncomplicated urinary tract infection in adult womenAdhesive Pili in UTI Pathogenesis and Drug DevelopmentEarly severe inflammatory responses to uropathogenic E. coli predispose to chronic and recurrent urinary tract infectionDoes prolonged exposure to antibiotic-resistant bacteria increase the rate of antibiotic-resistant infection?Comparison of Escherichia coli strains recovered from human cystitis and pyelonephritis infections in transurethrally challenged miceRecurrent cystitis in non-pregnant women.Do therapeutic interventions stand the test of time?All dysuria is local. A cost-effectiveness model for designing site-specific management algorithms.Randomized, placebo-controlled phase 2 trial of a Lactobacillus crispatus probiotic given intravaginally for prevention of recurrent urinary tract infectionUropathogenic Escherichia coli superinfection enhances the severity of mouse bladder infection.Are you experienced? Understanding bladder innate immunity in the context of recurrent urinary tract infection.Population dynamics and niche distribution of uropathogenic Escherichia coli during acute and chronic urinary tract infection.Treatment duration for urinary tract infections in adults.Inhibition of Cyclooxygenase-2 Prevents Chronic and Recurrent Cystitis.Developing clinical rules to predict urinary tract infection in primary care settings: sensitivity and specificity of near patient tests (dipsticks) and clinical scores.Binding of uropathogenic Escherichia coli R45 to glycolipids extracted from vaginal epithelial cells is dependent on histo-blood group secretor status.Escherichia coli uropathogenesis in vitro: invasion, cellular escape, and secondary infection analyzed in a human bladder cell infection modelPerformance of a New Rapid Immunoassay Test Kit for Point-of-Care Diagnosis of Significant Bacteriuria.Establishment and Characterization of UTI and CAUTI in a Mouse Model.Clinical and bacteriological outcome of different doses and duration of pivmecillinam compared with placebo therapy of uncomplicated lower urinary tract infection in women: the LUTIW project.Pivmecillinam versus sulfamethizole for short-term treatment of uncomplicated acute cystitis in general practice: a randomized controlled trial.The treatment of urinary tract infections and use of ciprofloxacin extended release.Host-pathogen checkpoints and population bottlenecks in persistent and intracellular uropathogenic Escherichia coli bladder infection.Drug and Vaccine Development for the Treatment and Prevention of Urinary Tract Infections.A FimH inhibitor prevents acute bladder infection and treats chronic cystitis caused by multidrug-resistant uropathogenic Escherichia coli ST131.Recurrent urinary tract infections in healthy and nonpregnant womenPositively selected FimH residues enhance virulence during urinary tract infection by altering FimH conformationSystematic review and meta-analysis of antimicrobial treatment effect estimation in complicated urinary tract infection.The unexplored relationship between urinary tract infections and the autonomic nervous system.Potential host-related risk factors for recurrent urinary tract infection in Saudi women of childbearing age.Bacterial virulence phenotypes of Escherichia coli and host susceptibility determine risk for urinary tract infections.Urinary tract infection in primary health care in northern Sweden. II. Clinical presentation.The natural course of uncomplicated lower urinary tract infection in women illustrated by a randomized placebo controlled study.Ocean Spray Cranberry Products® and urinary tract infection in women - Scientific substantiation of a health claim related to Ocean Spray Cranberry Products® and urinary tract infection in women pursuant to Article 14 of Regulation (EC) No 1924/2006Functional role of the type 1 pilus rod structure in mediating host-pathogen interactions.Urinary tract infection in primary health care in northern Sweden. I. Epidemiology.Clinical and bacteriological effects of therapy of urinary tract infection in primary health care: relation to in vitro sensitivity testing.
P2860
Q24186322-DB6495C7-EBD0-46D2-8C4B-D79D135E0951Q24202838-18AF8997-D855-48A3-8D29-6426071A8D7EQ24235179-8B80A79B-D5D1-4490-AF1C-4E61D27DB6BEQ24534412-CD634945-4EDE-4E09-B32B-ABC65645A7F2Q26752944-1DFC0C5D-10A8-49E6-9CA0-04D5C7D03419Q28475353-73CA1FFD-E137-415F-9D2F-6703FF038A48Q33740992-B0EE8F66-7196-4072-BA42-6DA0120AF5AEQ33755910-E4EB8055-1F4B-4988-A3A1-065F1E719644Q34011369-BD1C1026-BB61-4D16-9D3D-2641A2DB198EQ34369874-AB8270BC-3CD0-477D-A132-52BBB614DBC0Q34732407-DECFB6A7-F936-4B38-A9E4-D8AA99585DDEQ34814831-B546B4C0-AC87-408C-BFC8-23DE1ADC288DQ34876396-F037DCFC-41E4-4F55-BB88-DB289A3C2586Q35195313-38DDD6ED-B130-45AC-A3C3-E2BBE217D058Q35273075-56EA4049-7B33-4DAA-A3C1-238FBA7D94CEQ35535312-9258E265-B82A-4EC9-A276-12C3B9FBFE72Q35687994-FB45D170-095D-4ED6-9A7F-64B0B962AD3BQ35804285-F16B79F9-3F9D-44FE-86F1-AE41CDE17230Q35822048-D9FE3AC8-4B77-4515-9F80-78368DCF2988Q35944034-664BFF1A-17E7-4F73-BDF9-63DDB5D691DAQ35968655-F81F75D6-5B3C-442C-9EA0-DCB1FE73F668Q35980554-CB2E3C78-4CFE-4B9B-B16B-92BD960DB082Q36075393-C17982E2-CE1C-4E3C-8DEE-E3B5FF92A4F6Q36135488-75DB74F1-BB60-4DE8-BCDF-30CE9359C9B2Q36458378-EF17FF71-3037-47E6-BF1C-66C886EE240AQ36910650-002C0900-E0FE-40BC-B5E9-0C7BC307B955Q36951570-095A0FEE-13C0-4798-9942-81908AE09A6FQ37109522-27BCAB57-C697-4EB3-8AF6-E27FF094445BQ37152657-07EC02A9-E1CD-44C8-9A6E-7024CC1DBF2CQ37204032-CAF9FDE1-6368-478A-8906-222371C49096Q37263472-DD56FDF2-D350-4F43-9583-298E73321418Q38537188-AFB37870-229D-4AE9-9269-F281EA478DE4Q40000851-49474C4E-4A8D-407C-82E4-2652EBAF9058Q40283099-203CC110-AE29-49F9-B54F-E0564FC16DA9Q43673621-B35D7D1F-92FB-4CD1-A1DB-7CE7FE8BAF50Q44937349-270D2EA4-58B6-4CE4-944C-A8B673206F05Q47146307-4B10010D-8CB6-450F-8396-D7D2A5E4B928Q48042261-D79428C3-4F8F-4E43-A5CD-846B6D4C025EQ50573899-5F7DDED9-9307-46EB-BE45-69BBA4199EF0Q54393973-F2EC6F30-9AC7-406F-874B-CCB002282F42
P2860
Treatment of uncomplicated urinary tract infection in non-pregnant women.
description
1972 nî lūn-bûn
@nan
1972年の論文
@ja
1972年論文
@yue
1972年論文
@zh-hant
1972年論文
@zh-hk
1972年論文
@zh-mo
1972年論文
@zh-tw
1972年论文
@wuu
1972年论文
@zh
1972年论文
@zh-cn
name
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@ast
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@en
type
label
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@ast
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@en
prefLabel
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@ast
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@en
P2860
P356
P1476
Treatment of uncomplicated urinary tract infection in non-pregnant women.
@en
P2093
P2860
P356
10.1136/PGMJ.48.556.69
P407
P577
1972-02-01T00:00:00Z